Bovine leukaemia virus ISCOMs: biochemical characterization

Area of Science:

• Veterinary Virology
• Immunology
• Biochemistry

Background:

• Bovine leukaemia virus (BLV) causes significant economic losses in the cattle industry.
• The surface glycoprotein gp51 is a key target for neutralizing antibodies.
• Immunostimulating complexes (ISCOMs) are potent vaccine adjuvants that can enhance immune responses.

Purpose of the Study:

• To characterize BLV-gp51 incorporated into ISCOMs.
• To evaluate the antigenicity and immunogenicity of BLV-gp51 within ISCOMs.
• To determine the optimal detergent for ISCOM preparation preserving neutralizing epitopes.

Main Methods:

• Biochemical characterization of ISCOMs using SDS-PAGE and immunoblotting.
• Analytical ultracentrifugation to determine S-value and electron microscopy for structural analysis.
• Development of an ELISA using monoclonal antibodies to assess epitope exposure and antigenicity.

Main Results:

• BLV-gp51 was successfully incorporated into ISCOMs, which exhibited characteristic cage-like structures.
• ISCOMs prepared using Tween-20, Tween-80, or octyl glucoside retained reactivity with neutralizing monoclonal antibodies, unlike those made with Triton X-100 or MEGA.
• Neutralizing epitopes on gp51 were found to be better exposed in ISCOMs compared to other epitopes.
• Preliminary experiments indicated that gp51 within ISCOMs is highly immunogenic.

Conclusions:

• ISCOMs are a suitable platform for presenting BLV-gp51, preserving crucial neutralizing epitopes.
• The choice of detergent is critical for maintaining the antigenicity of gp51 in ISCOMs.
• BLV-gp51 ISCOMs demonstrate significant potential as immunogens for developing effective vaccines against BLV infection.